| View |
|
DRP-10813
|
Amlodipine (as besilate) + Valsartan
|
None
|
5 mg/160 mg
|
Film-Coated Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
29 November 2021
|
29 November 2026
|
| View |
|
DR-XY47563
|
Dexamethasone phosphate (as sodium)
|
Eodex
|
4 mg/mL (8 mg/2mL)
|
Solution for Injection
(I.V./I.M.)
|
-
|
Zee Laboratories Limited
|
India
|
Initial (re-issuance)
|
12 August 2022
|
23 November 2026
|
| View |
|
DRP-3183-05
|
Losartan (As Potassium)
|
None
|
50 mg
|
Film-Coated Tablet
|
Angiotensin-II-Receptor Blocker (ARB)
|
XL Laboratories Pvt. Ltd.
|
India
|
-
|
03 March 2022
|
07 June 2027
|
| View |
|
DRP-3712-02
|
Clindamycin (as hydrochloride)
|
Peldacyn
|
300mg
|
Capsule
|
Antibacterial (Lincosamide)
|
S.C. Sandoz S.R.L.
|
Romania
|
Renewal
|
26 November 2021
|
23 October 2028
|
| View |
|
DRP-3712-03
|
Clindamycin (as hydrochloride)
|
Unbranded
|
300mg
|
Capsule
|
Antibacterial (Lincosamide)
|
S.C. Sandoz S.R.L.
|
Romania
|
Renewal
|
24 November 2021
|
23 October 2028
|
| View |
|
BRP-049-03
|
Filgrastim
|
Cellacyte
|
300 mcg/0.5 mL
|
Solution for Injection (IV/SC)
|
Colony Stimulating Factors
|
Reliance Life Sciences Pvt. Ltd. (Plant II)
|
India
|
Automatic Renewal
|
08 July 2022
|
28 September 2027
|
| View |
|
DRP-3881-01
|
Montelukast
|
Primear
|
10 mg
|
Chewable Tablet
|
Leukotriene Receptor Antagonist
|
Rainbow Life Sciences Pvt Ltd.
|
India
|
Automatic Renewal
|
25 October 2022
|
05 April 2028
|
| View |
|
DRP-7337
|
Bortezomib
|
Zomob 3.5
|
3.5 mg
|
Lyophilized Powder for Injection (IV/SC)
|
Antineoplastic Agent
|
Intas Pharmaceuticals Limited
|
India
|
Automatic Renewal
|
13 October 2022
|
14 September 2027
|
| View |
|
DRP-10807
|
Lactulose
|
Lactokhriz
|
3.33 g/5 mL
|
Oral Solution
|
Laxative
|
Rhydburg Pharmaceuticals Ltd.
|
India
|
Initial
|
25 November 2021
|
25 November 2026
|
| View |
|
DR-XY47578
|
Perampanel
|
Fycompa
|
500 mcg/ mL
|
Oral Suspension
|
-
|
Delpharm Huningue SAS
|
France
|
-
|
02 December 2021
|
02 December 2026
|
| View |
|
DRHR-189
|
Benzoic Acid + Salicylic Acid
|
Whitfield's Ointment
|
2 g/ 6 g per 100 g
|
Ointment
|
-
|
International Pharmaceuticals, Inc.
|
Philippines
|
-
|
23 March 2021
|
23 March 2026
|
| View |
|
DRP-10695
|
Loratadine + Phenylephrine Hydrochloride
|
Loraped
|
5 mg/5 mg per 5 mL
|
Syrup
|
-
|
Amherst Laboratories, Inc.
|
Philippines
|
-
|
10 November 2021
|
31 August 2025
|
| View |
|
DRP-4220
|
Tamsulosin Hydrochloride
|
Sultam
|
200 mcg
|
Enteric-Coated Tablet
|
Alpha-Adrenoceptor Antagonist
|
Unicure Remedies Pvt. Ltd.
|
India
|
Renewal
|
15 June 2022
|
03 August 2027
|
| View |
|
DR-XY37755
|
Domperidone
|
Perilax
|
10mg
|
Tablet
|
-
|
Towa Pharmaceutical Co. Ltd.
|
Japan
|
-
|
12 November 2021
|
08 April 2025
|
| View |
|
DRP-3715-08
|
Ceftriaxone (As Sodium)
|
Starcef
|
1 g
|
Powder For Injection (IM/IV)
|
Antibacterial (Cephalosporin)
|
Zazen Pharma Pvt. Ltd.
|
India
|
Automatic Renewal
|
05 June 2023
|
28 September 2028
|
| View |
|
DRP-9395
|
Each kit contains:
Pyrazinamide 250 mg/ 5mL Suspension (Pyzather) Rifampicin 200 mg/ 5 mL Suspension (Fampisec)
Isoniazid 200 mg/5 mL Syrup (Bacciter Forte)
|
Tri Pedia Kit
|
Each kit contains:
Pyrazinamide 250 mg/ 5mL Suspension (Pyzather) Rifampicin 200 mg/ 5 mL Suspension (Fampisec)
Isoniazid 200 mg/5 mL Syrup (Bacciter Forte)
|
Suspension/Suspension/Syrup
|
Antituberculosis
|
San Marino Laboratories Corporation
|
Philippines
|
Automatic Renewal
|
17 February 2023
|
07 April 2028
|
| View |
|
DR-XY47592
|
Cefuroxime (as axetil)
|
Zegen
|
250mg
|
Film-Coated Tablet
|
Antibacterial (Cephalosporin)
|
P.T. Darya Varia Laboratories Tbk
|
Indonesia
|
Initial
|
09 December 2021
|
09 December 2026
|
| View |
|
DRP-10879
|
Ascorbic Acid + Zinc
|
C-4 Zink
|
500mg (equivalent to 562.40mg Sodium Ascorbate) /
10mg (equivalent to 27.50mg Zinc Sulfate
Monohydrate)
|
Capusle
|
Vitamin / Mineral
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
Initial
|
10 December 2021
|
10 December 2026
|
| View |
|
DRP-10881
|
Trimetazidine hydrochloride
|
Zim-Dine
|
35 mg
|
Modified Release Tablet
|
Anti-angina (Fatty Acid Oxidation (p FOX] Inhibitor)
|
Zim Laboratories Limited
|
India
|
Initial
|
10 December 2021
|
10 December 2026
|
| View |
|
DRP-6089-09
|
Ascorbic Acid (as Sodium Ascorbate) + Zinc (as Sulfate Monohydrate)
|
Vitamoon Plus
|
100 mg (equiv. to 112.5 mg Sodium Ascorbate) / 10 mg / 5 mL
|
Syrup
|
Vitamin and Mineral
|
LifeSquare Laboratories, Inc.
|
Philippines
|
Renewal
|
21 July 2022
|
06 July 2027
|